Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05910307 · ClinicalTrials.gov registry record
Synovial Sarcoma Registry / Biospecimen Repository
A clinical trial of Synovial Sarcoma, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT05910307: Recruiting study of Synovial Sarcoma, sponsored by Children's Hospital of Philadelphia.
NCT05910307 is a study of Synovial Sarcoma that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 1,000 participants, above the 66-participant average among 11 other Synovial Sarcoma trials with a reported enrollment target (1415% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05910307, a study of Synovial Sarcoma, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect and store data and samples for future research to attempt to improve outcomes for patients with synovial sarcoma. The future research will involve various types of genetic testing. Participants will be asked to allow access to medical records and leftover tumor tissue and may be asked to give a blood or saliva sample. Participants will also be asked to completed questionnaires about their medical history and may be contacted every 6 to 12 months for updates for up to 10 years.
Primary Outcome
Number of patients with synovial sarcoma
Conditions Studied
Study Locations (1)
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-06-12 |
| Est. Completion | 2033-06 |
What NCT05910307 shows while recruiting
NCT05910307 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus, above the 66-participant average among 11 other Synovial Sarcoma trials with a reported enrollment target (1415% higher).
The record links to 1 condition, with Synovial Sarcoma appearing as the primary indexed condition, and to 0 interventions.
NCT05910307 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05910307 about?
NCT05910307 is a clinical study titled "Synovial Sarcoma Registry / Biospecimen Repository". The purpose of this study is to collect and store data and samples for future research to attempt to improve outcomes for patients with synovial sarcoma. The future research will involve various types of genetic testing. Participants will be asked to allow access to medical records and leftover tum...
What is the current status of trial NCT05910307?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-06-12. Estimated completion is 2033-06.
What conditions does trial NCT05910307 study?
This clinical trial studies the following conditions: Synovial Sarcoma.
Who is sponsoring clinical trial NCT05910307?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05910307 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Synovial Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05910307's enrollment target sits among peer trials
1,000 1st of 11 higher than 11 of 11 other Synovial Sarcoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Synovial Sarcoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1
RECRUITING · Phase 1
-
ACTengine® IMA203 Combined With mRNA-4203
RECRUITING · Phase 1
-
Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
RECRUITING · Phase 1
-
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
RECRUITING · Phase 1
-
SPEARHEAD-3 Pediatric Study
RECRUITING · Phase 1
-
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI